Hypothesis

Aging is driven by a conserved, actively maintained senescence execution program that is suppressed when extrinsic mortality is low and somatic investment yields inclusive‑fitness benefits. The program functions as a conditional switch: under high extrinsic mortality (typical post‑reproductive environments) it promotes timely death to free resources for kin; under low extrinsic mortality it is attenuated, allowing extended somatic maintenance without compromising early‑life fitness.

Mechanistic Basis

• The execution program centers on the mitochondrial permeability transition pore (mPTP) complex, whose opening triggers a cascade of oxidative damage and inflammasome activation that culminates in organismal decline.
• mPTP activity is regulated by the NAD⁺‑dependent deacetylase SIRT3 and by circulating kin‑signaling peptides (e.g., insulin‑like growth factor binding proteins) that rise when population density is high and relatedness is elevated.
• When extrinsic mortality is low, reduced stress signaling lowers cytosolic Ca²⁺ and ROS, keeping mPTP closed; SIRT3 activation further raises the threshold for pore opening. This creates a reversible, physiologically tunable senescence brake.
• The system aligns with antagonistic pleiotropy: alleles that enhance early‑life growth and reproduction modestly increase basal mPTP sensitivity, a cost that is only realized when the environmental cue for low extrinsic mortality is absent.

Testable Predictions

1. In C. elegans, exposure to a pheromone blend that signals high population density will increase mPTP opening rates in intestinal muscle and shorten lifespan, even when daf‑2 insulin signaling is attenuated.
2. Pharmacological elevation of NAD⁺ (via NR supplementation) will raise the ROS threshold for mPTP opening and extend lifespan only in conditions where extrinsic mortality cues are experimentally minimized (e.g., low‑temperature, predator‑free chambers).
3. Knock‑out of the mitochondrial cyclophilin D (CypD) component will abolish the lifespan‑shortening effect of high‑density pheromone exposure without affecting early‑life fecundity.
4. Human plasma from individuals living in low‑mortality, high‑resource societies will show higher SIRT3 activity and lower circulating mPTP‑activating lipids compared with age‑matched individuals from high‑mortality settings.

Experimental Approaches

• Use CRISPR‑edited C. elegans lines expressing a fluorescent mPTP reporter to quantify pore dynamics under controlled pheromone concentrations.
• Apply intermittent NR dosing in Drosophila cohorts subjected to simulated predation cues (vibrations) and measure survival, offspring number, and CypD‑dependent ROS production.
• Perform GWAS interaction analyses testing whether NAD⁺‑biosynthesis variants modify the effect size of late‑life disease alleles across socioeconomic strata (proxy for extrinsic mortality).
• Collect serum from cohorts in contrasting mortality environments (e.g., rural high‑infectious‑disease vs. urban low‑infectious‑disease settings) and assay SIRT3 activity, CypD levels, and mPTP‑sensitive metabolites.

If these predictions hold, aging can be viewed as a conditionally executed program rather than a simple accumulation of damage, suggesting that longevity interventions should aim to modulate the environmental inputs that keep the senescence switch in the "off" state rather than merely repairing downstream damage.

1 2 3 4 5